There are a bazillion autism treatments and therapies out there today. At treatments4autism, we take a look at all of them. From the goofy, like dolphin therapy, to the interesting like Lego therapy, to the down right essential like ABA.

A Denver biotech company and Los Angeles nonprofit foundation dedicated to the treatment of autism are disavowing their previously announced partnership with UC Irvine.

The clarification comes more into focus when you know the players. The firm, Cannabis Science, develops pharmaceutical products from marijuana plants. The Unconventional Foundation for Autism (UF4A) promotes cannabis-based medical research and clinical trials for those afflicted with the disorder.

"To date, we have already partnered with the University of California Irvine Medical Center to oversee our cannabis-based Autism research. Included in this group of advisors is the Dean of Medicine at UCI, and child psychiatrist Dr. Rebecca Hedrick, M.D."

The use of cannabis to treat autism is portrayed as the subject of a presentation Hedrick made earlier this year, according to the UF4A website.

Cannabis Science wishes to clarify that the partnership is only a partnership with UF4A. Cannabis Science has no relationship or affiliation with the University of California, Irvine, the Dean of the UCI School of Medicine, or any of its faculty ("UCI"). UF4A has no affiliation with UC Irvine, though UC Irvine psychiatrist treats the autistic son of UF4A founder, Mieko Hester-Perez. Neither UCI nor Dr. Hedrick is conducting research into medical marijuana and autism.